Close Menu

FDA

Celera's revenues were driven by sales of its KIF6 testing service, but the firm posted a loss for the second quarter in a row on higher SG&A spending related to building its infrastructure following its split from Applera.

Short Reads

Premium

Life Technologies, Max Planck Institute for Evolutionary Anthropology, 454 Life Sciences, Applied Biosystems, Baylor College of Medicine, University of Bristol, University of Liverpool, John Innes Centre, Helicos BioSciences, Febit, and more…

TrimGen is the latest of several molecular diagnostics players to receive FDA OK for their warfarin sensitivity assays.

BioArray Briefs: 2009.02.17

Premium

SQI Diagnostics, Olink Bioscience, Innova Biosciences, Copenhagen University, Fujirebio Diagnostics, Uppsala University, Integromics, Gene Logic, Ocimum Biosolutions

Despite increasing evidence that the action of some drugs is influenced by patient genetics, testing for such variants has not been widely adopted as part of standard practice, AAAS meeting attendees heard this weekend.

LabCorp becomes the first clinical lab firm in the US to offer the recently FDA-cleared HCV test.

The agency and the consortium will make available genomic data about drug-induced reactions causing skin rashes.

The molecular diagnostics firm's decline in sales to clinical partners and biothreat customers was the primary cause of its expected decrease in Q4 revenues. It also announced a series of measures aimed at reining in costs in 2009.

A company official said Hong Kong may be the best place to conduct the phase I study since data collected may be used in both US and Chinese regulatory filings.

The agency has created a new science spot to coordinate and upgrade its genomics programs.

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.